Skip to main content

TableĀ 3 Foundation one histology distribution

From: A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

Disease

n

All CDKN2A

Copy #

Rearrangements

SNV: somatic

SNV: germline

SNV: unknown

SNV: all

Multiple alterations

All soft tissue sarcoma

7733

16.7

14.0

0.4

1.1

0.2

0.7

2.0

0.3

Malignant peripheral nerve sheath tumor (MPNST)

262

60.7

48.1

5.3

5.0

0.4

1.5

6.9

0.4

Myxofibrosarcoma

140

29.3

23.6

1.4

2.1

0.7

0.7

3.6

0.7

Undifferentiated pleomorphic sarcoma (UPS)

372

29

21.5

0.3

5.1

0.0

1.3

6.5

0.8

Soft tissue sarcoma (NOS)

1476

28.9

25.4

0.4

1.3

0.3

1.1

2.6

0.5

Fibrosarcoma

99

26.3

22.2

0.0

2.0

0.0

1.0

3.0

1.0

Clear cell sarcoma

72

23.6

18.1

0.0

0.0

1.4

2.8

4.2

1.4

Epithelioid sarcoma

72

20.8

18.1

0.0

2.8

0.0

0.0

2.8

0.0

Perivascular epithelioid cell tumor (PEComa)

58

20.7

15.5

0.0

1.7

1.7

1.7

5.2

0.0

Angiosarcoma

292

20.2

16.4

0.3

1.7

0.3

1.0

3.1

0.3

Endometrial stromal sarcoma

200

15

12.5

0.0

0.5

0.0

2.0

2.5

0.0

Rhabdomyosarcoma (Embryonal)

96

14.6

10.4

2.1

1.0

0.0

1.0

2.1

0.0

Rhabdomyosarcoma (NOS)

199

14.1

12.1

0.0

2.0

0.0

0.0

2.0

0.0

Hemangioendothelioma

68

10.3

7.4

0.0

2.9

0.0

0.0

2.9

0.0

Uterus leiomyosarcoma

678

10.2

9.3

0.3

0.1

0.1

0.1

0.4

0.1

Inflammatory myofibroblastic tumor

62

9.7

8.1

0.0

0.0

0.0

0.0

0.0

1.6

Uterus sarcoma (NOS)

129

9.3

8.5

0.8

0.0

0.0

0.0

0.0

0.0

Unknown primary leiomyosarcoma

206

8.7

7.8

0.0

0.0

0.0

1.0

1.0

0.0

Rhabdomyosarcoma (Alveolar)

101

6.9

5.0

0.0

0.0

1.0

1.0

2.0

0.0

Leiomyosarcoma

924

6.4

5.2

0.0

0.4

0.2

0.3

1.0

0.2

Solitary fibrous tumor

149

6

6.0

0.0

0.0

0.0

0.0

0.0

0.0

Breast angiosarcoma

70

5.7

5.7

0.0

0.0

0.0

0.0

0.0

0.0

Synovial sarcoma

321

5

4.0

0.0

0.0

0.0

0.6

0.6

0.3

Liposarcoma

805

5

4.5

0.1

0.1

0.1

0.1

0.4

0.0

Desmoplastic small round cell tumor

113

4.4

4.4

0.0

0.0

0.0

0.0

0.0

0.0

Alveolar soft part sarcoma (ASPS)

72

4.2

2.8

0.0

1.4

0.0

0.0

1.4

0.0